1. Xu, Min, Zheng, Jie, Hou, Tianzhichao, Bi, Yufang, Wang, Weiqing. SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study. Diabetes care, 45, 2718-2728. doi:10.2337/dc22-0323.
2. Li, Jiang, Yu, Yuefeng, Sun, Ying, Lu, Yingli, Wang, Ningjian. SGLT2 inhibition, circulating metabolites, and atrial fibrillation: a Mendelian randomization study. Cardiovascular diabetology, 22, 278. doi:10.1186/s12933-023-02019-8.
3. Fang, Xinyi, Miao, Runyu, Wei, Jiahua, Wu, Haoran, Tian, Jiaxing. Advances in multi-omics study of biomarkers of glycolipid metabolism disorder. Computational and structural biotechnology journal, 20, 5935-5951. doi:10.1016/j.csbj.2022.10.030.
4. Rieg, Timo, Vallon, Volker. Development of SGLT1 and SGLT2 inhibitors. Diabetologia, 61, 2079-2086. doi:10.1007/s00125-018-4654-7.
5. Guo, Wenqin, Zhao, Lingyue, Huang, Weichao, Peng, Changnong, Yan, Hongbing. Sodium-glucose cotransporter 2 inhibitors, inflammation, and heart failure: a two-sample Mendelian randomization study. Cardiovascular diabetology, 23, 118. doi:10.1186/s12933-024-02210-5.
6. Xu, Bo, Li, Shaoqian, Kang, Bo, Tang, Fan, Zhou, Jiecan. Role of SLC5A2 polymorphisms and effects of genetic polymorphism on sodium glucose cotransporter 2 inhibitorsinhibitor response. Molecular biology reports, 50, 9637-9647. doi:10.1007/s11033-023-08836-0.
7. Wang, Sai, Wang, Yixiu, Wang, Jinchao, Bottillo, Irene, Shao, Leping. Six Exonic Variants in the SLC5A2 Gene Cause Exon Skipping in a Minigene Assay. Frontiers in genetics, 11, 585064. doi:10.3389/fgene.2020.585064.
8. Dorum, Sevil, Erdoğan, Hakan, Köksoy, Adem Yasin, Topak, Ali, Görükmez, Özlem. Clinical features of pediatric renal glucosuria cases due to SLC5A2 gene variants. Pediatrics international : official journal of the Japan Pediatric Society, 64, e14948. doi:10.1111/ped.14948.
9. Panico, Cristina, Felicetta, Arianna, Kunderfranco, Paolo, Greco, Carolina M, Condorelli, Gianluigi. Single-Cell RNA Sequencing Reveals Metabolic Stress-Dependent Activation of Cardiac Macrophages in a Model of Dyslipidemia-Induced Diastolic Dysfunction. Circulation, 150, 1517-1532. doi:10.1161/CIRCULATIONAHA.122.062984.
10. Tomita, Issei, Kume, Shinji, Sugahara, Sho, Araki, Shin-Ichi, Maegawa, Hiroshi. SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition. Cell metabolism, 32, 404-419.e6. doi:10.1016/j.cmet.2020.06.020.
参考文献：
智鼠故事 
